The Wnt/β-catenin pathway is important for replication of SARS-CoV-2 and other pathogenic RNA viruses
- Npj Viruses. 2024 Feb 21;2(1):6. doi: 10.1038/s44298-024-00018-4.
- 1. Department of Cell Biology, University of Alberta, Edmonton, AB, Canada.
- 2. Department of Poultry Diseases, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
- 3. Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, AB, Canada.
- 4. Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
- 5. Department of Medicine, University of Alberta, Edmonton, AB, Canada.
- 6. Department of Chemistry, University of Alberta, Edmonton, AB, Canada.
- 7. Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon, SK, Canada.
- 8. Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada.
- 9. Department of Cell Biology, University of Alberta, Edmonton, AB, Canada. [email protected].
- 10. Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, AB, Canada. [email protected].
- 11. Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada. [email protected].
- # Contributed equally.
Understanding how viruses affect cellular pathways during Infection may facilitate development of host cell-targeted therapeutics with broad-spectrum Antiviral activity. The interferon (IFN) response is critical for reducing replication and pathogenesis of many viruses including Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. Mounting evidence indicates that peroxisomes which are best known as metabolic organelles, function in the IFN response. Recently, we reported that the Wnt/β-catenin signaling pathway strongly suppresses peroxisome biogenesis. Here, we show that SARS-CoV-2 Infection activates Wnt/β-catenin signaling and hypothesized that pharmacological inhibition of this pathway would result in increased peroxisome formation and enhanced IFN production. Indeed, Wnt/β-catenin signaling potently inhibits replication of SARS-CoV-2 and Other pathogenic RNA viruses in vitro and reduces viral load, inflammation and clinical symptoms in a mouse model of COVID-19. As such, targeting this cellular pathway may have prophylactic and/or therapeutic value in reducing the disease burden caused by emerging viral pathogens.